PT93488A - Processo de preparacao de composicoes farmaceuticas a base de (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona e destes compostos numa forma pura e cristalina - Google Patents

Processo de preparacao de composicoes farmaceuticas a base de (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona e destes compostos numa forma pura e cristalina

Info

Publication number
PT93488A
PT93488A PT93488A PT9348890A PT93488A PT 93488 A PT93488 A PT 93488A PT 93488 A PT93488 A PT 93488A PT 9348890 A PT9348890 A PT 9348890A PT 93488 A PT93488 A PT 93488A
Authority
PT
Portugal
Prior art keywords
alpha
pregn
hydroxy
methyl
pure
Prior art date
Application number
PT93488A
Other languages
English (en)
Other versions
PT93488B (pt
Inventor
Gerard Arnoud Josef Maria Sas
Emile Martin Van Doornum
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19854317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT93488(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of PT93488A publication Critical patent/PT93488A/pt
Publication of PT93488B publication Critical patent/PT93488B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT93488A 1989-03-18 1990-03-16 Processo de preparacao de composicoes farmaceuticas a base de (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona e destes compostos numa forma pura e cristalina PT93488B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8900673 1989-03-18

Publications (2)

Publication Number Publication Date
PT93488A true PT93488A (pt) 1990-11-07
PT93488B PT93488B (pt) 1996-02-29

Family

ID=19854317

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93488A PT93488B (pt) 1989-03-18 1990-03-16 Processo de preparacao de composicoes farmaceuticas a base de (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona e destes compostos numa forma pura e cristalina

Country Status (17)

Country Link
US (1) US5037817A (pt)
EP (1) EP0389035B1 (pt)
JP (2) JP3139709B2 (pt)
KR (1) KR0183401B1 (pt)
AT (1) ATE98490T1 (pt)
AU (1) AU625083B2 (pt)
CA (1) CA2011452C (pt)
DE (1) DE69005165T2 (pt)
DK (1) DK0389035T3 (pt)
ES (1) ES2062292T3 (pt)
FI (1) FI94865C (pt)
HK (1) HK1002019A1 (pt)
IE (1) IE63051B1 (pt)
MX (1) MX9203787A (pt)
NZ (1) NZ232946A (pt)
PT (1) PT93488B (pt)
ZA (1) ZA901674B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA941464B (en) * 1993-03-05 1994-09-27 Akzo Nv Use of pregnane derivative
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
IL123984A (en) 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
TW577893B (en) * 1998-10-16 2004-03-01 Akzo Nobel Nv High purity composition comprising (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
US7045513B1 (en) 1999-03-18 2006-05-16 Genelabs Technologies, Inc. DHEA composition and method
RU2220727C2 (ru) * 1999-03-18 2004-01-10 Дженелабс Текнолоджис, Инк. Композиция, содержащая дегидроэпиандростерон, и способы ее изготовления и применения
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
EP1444247B1 (en) * 2001-10-18 2007-06-13 Norton Healthcare Limited Tibolone formulations
EP1469861A1 (en) * 2002-01-22 2004-10-27 Akzo Nobel N.V. Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
CN1324041C (zh) * 2003-04-01 2007-07-04 上海迪赛诺医药科技开发有限公司 替勃龙晶型i的制备方法
MXPA05000824A (es) * 2003-05-23 2005-04-28 Akzo Nobel Nv Forma de dosis farmaceutica de liberacion inmediata que contiene tibolona polimorfa.
EP1883648A1 (en) * 2005-05-23 2008-02-06 Newchem S.p.A. Process for the preparation of pure crystalline tibolone
EP1821571A1 (en) * 2006-02-15 2007-08-22 Oticon A/S Loop antenna for in the ear audio device
ITMI20130120A1 (it) * 2013-01-25 2014-07-26 Ind Chimica Srl Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one
HUE055164T2 (hu) 2016-05-04 2021-11-29 Novalon S A Cukoralkoholok alkalmazása Tobolon tartalmú készítményekben

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (pt) * 1964-06-16
US4933168A (en) * 1975-05-27 1990-06-12 Syntex Pharmaceuticals International Limited Stable, crystalline flunisolide
US4273710A (en) * 1979-05-21 1981-06-16 Syntex Corporation Process for preparing flunisolide
US4447426A (en) * 1982-01-18 1984-05-08 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4391755A (en) * 1982-01-18 1983-07-05 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators

Also Published As

Publication number Publication date
PT93488B (pt) 1996-02-29
EP0389035A1 (en) 1990-09-26
AU5139490A (en) 1990-09-20
DE69005165D1 (de) 1994-01-27
MX9203787A (es) 1992-07-01
AU625083B2 (en) 1992-07-02
FI901328A0 (fi) 1990-03-16
DE69005165T2 (de) 1994-05-05
EP0389035B1 (en) 1993-12-15
HK1002019A1 (en) 1998-07-24
FI94865B (fi) 1995-07-31
FI94865C (fi) 1995-11-10
ES2062292T3 (es) 1994-12-16
JP2001139473A (ja) 2001-05-22
JPH0347195A (ja) 1991-02-28
ZA901674B (en) 1990-12-28
US5037817A (en) 1991-08-06
KR0183401B1 (ko) 1999-05-01
CA2011452C (en) 1999-05-25
CA2011452A1 (en) 1990-09-18
KR900013950A (ko) 1990-10-22
IE63051B1 (en) 1995-03-22
JP3139709B2 (ja) 2001-03-05
IE900709L (en) 1990-09-18
NZ232946A (en) 1991-08-27
DK0389035T3 (da) 1994-02-14
ATE98490T1 (de) 1994-01-15

Similar Documents

Publication Publication Date Title
PT93488A (pt) Processo de preparacao de composicoes farmaceuticas a base de (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona e destes compostos numa forma pura e cristalina
FI903429A0 (fi) Kompositioner av vattenloesliga peptider med foerdroejd frigoering.
PT87820A (pt) Process for the preparation of 1,2,3,5,6-tetrahydro-pyridile anof pyperidile compounds and pharmaceutical compositions therewi
IT8721365A0 (it) Dentiere. composizioni resinose per base di
NO900742D0 (no) Sammenstilling av verktoeydeler.
KR910700089A (ko) 히드로클로로플루오로프로판의 공비 조성물 또는 공비형 조성물
IT1246445B (it) Composizioni farmaceutiche con migliorate proprieta' di dissoluzione.
NO912992L (no) 1-aminopropandiol-2,3 med hoey renhet, samt fremgangsmaate for fremstilling av forbindelsen.
ES2085898T3 (es) Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
OA09192A (en) "Stabilized sulfur dissolving compositions".
BR8904806A (pt) Processo para a preparacao de mercapto-bis-(1,3,4-oxa e tiadiazois)e composicao praguicida
ITMI910284A1 (it) Processo per la preparazione di 2, 2, 6, 6-tetrametil-4-piperidilammine
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
IT8747551A0 (it) 8 alfa acilamminoergoline ,loro preparazione e loro impiego come medicamenti
DE69012882D1 (de) Herstellung von Stickstoffzusammensetzungen.
PT84750B (pt) Processo de preparacao de uma composicao para o envenenamento de roedores, a base de derivados de 1,4-naftoquinona
IT8819731A0 (it) Composizioni farmaceutiche contenenti timosina alfa 1.
PT92682A (pt) Processo para a preparacao de uma composicao a base de trimebutina de libertacao prolongada
PT86665A (pt) Process for the preparation of 14,15-substituted lanosterols and of hypocholesterolemic compositions containing the same
IT1247618B (it) Procedimento per la fabbricazione di rivestimenti decorativi per i mobili d'arredamento
IT8948465A0 (it) Procedimento per produrre stecche di sapone duro translucido ad alto tenore di umidita'
IT1226147B (it) Processo per la preparazione di perfluoro (2 bromoetilviniletere).
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
IT8621925A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.
ATE90942T1 (de) (3-diethylaminopropyl)-1-amino-5methyldipyrido(4,3-b>(3,4-f>indoltrihydrochlori .

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19951120

PC4A Transfer of assignment

Owner name: N.V. ORGANON, NL

Effective date: 20061124

PD4A Change of proprietorship

Owner name: AKZO NOBEL N.V., NL

Effective date: 20061124

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20101122